Dr. Ania M. Jastreboff
Yale University School
Biography & Research Background
Ania M. Jastreboff, MD, PhD, is an Associate Professor of Medicine (Endocrinology) and Pediatrics (Pediatric Endocrinology) at Yale University School of Medicine, and Director of the Y-Weight Yale Obesity Research Center. Dr. Jastreboff served as the lead investigator for the pivotal SURMOUNT-1 trial, which established tirzepatide’s efficacy for obesity research application (up to 22.5% weight reduction), and led the 3-year follow-up demonstrating significant metabolic outcomes. Her landmark papers in the New England Journal of Medicine are among the most cited publications in obesity pharmacotherapy. Ania M. Jastreboff is being referenced as one of the leading scientists involved in the research and development of Tirzepatide. In no way is this doctor/scientist endorsing or advocating the purchase, sale, or use of this product for any reason. There is no affiliation or relationship, implied or otherwise, between Pure US Peptide and this doctor.
External Profiles
Authored Research Profiles (1)
Dr. Ania M. Jastreboff is referenced as a leading researcher in the following peptide research profiles on Pure U.S. Peptides:
Dr. Ania M. Jastreboff is being referenced as one of the leading scientists involved in the research and development of the peptides listed above. In no way is this doctor/scientist endorsing or advocating the purchase, sale, or use of any product for any reason. There is no affiliation or relationship, implied or otherwise, between Pure U.S. Peptides and this researcher. The purpose of citing the researcher is to acknowledge, recognize, and credit the exhaustive research and development efforts conducted by the scientists studying these peptides.